Pharmaceutical Technology on MSN
Solve Therapeutics raises $120m as MSD joins list of backers
In a year where ADC deals have showed no signs of slowing, Solve has become the latest biotech to unlock an extra slice of ...
MSD has announced a takeover deal for Cidara Therapeutics, an infectious disease specialist currently focused on developing a ...
Pharmaceutical Technology on MSN
MSD bets big on flu antivirals with $9.2bn buyout of Cidara
MSD has now agreed two deals around the $10bn mark in 2025 as it looks to shore up its pipeline with Keytruda’s looming ...
Pharmaceutical Technology on MSN
MSD secures $700m for broad-cancer ADC asset
ADCs remain à la mode in the oncology sector, with Merck & Co (MSD) tying up another deal to advance its pipeline in the ...
The LDL-C reductions seen with enlicitide in both studies are in the same ballpark as those seen with injectable ...
VIENNA--(BUSINESS WIRE)--Themis, a company focused on vaccines and immune-modulation therapies for infectious diseases and cancer and MSD (trademark of Merck & Co ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback